WHO Collaborating Centre for Sexually Transmitted Diseases, Sydney, Department of Microbiology, South Eastern Area Laboratory Services, Prince of Wales Hospital, Randwick, New South Wales 2031, Australia
Sydney Medical School Nepean, The University of Sydney, Nepean Hospital, Penrith, New South Wales 2747, Australia.
J Antimicrob Chemother. 2017 Feb;72(2):407-409. doi: 10.1093/jac/dkw406. Epub 2016 Oct 5.
Previous studies have shown that mixed-strain gonococcal infections can occur. However, it remains unclear whether such infections impact upon the reliability of Neisseria gonorrhoeae antimicrobial resistance (AMR) surveillance. In this study, we aimed to resolve this question by intensively sampling isolates from gonorrhoea-positive specimens in a high-risk population in Sydney, Australia.
A total of 615 N. gonorrhoeae isolates, originating from 63 clinical samples (31 rectal swabs and 32 throat swabs), were characterized. All isolates were subject to N. gonorrhoeae identification, antimicrobial susceptibility testing and genotyping by SNP-based MLST.
Only 2 of the 63 (3.2%) samples provided evidence of mixed-strain infections. These comprised two rectal swabs that harboured isolates of different SNP-based MLST genotypes; however, the AMR susceptibility profiles of the different genotypes from these samples were indistinguishable. Within-sample differences in the AMR susceptibility profiles were observed for a further seven samples; however, the differences were not considered significant; MIC values were typically within a 2-fold difference or were close to test breakpoints.
Results of this study provide further evidence that mixed-strain gonococcal infections do occur, although at low prevalence. Our data indicate that at a population level such infections are unlikely to impact significantly upon N. gonorrhoeae AMR surveillance.
先前的研究表明,淋病奈瑟菌混合菌株感染可能会发生。然而,目前尚不清楚这种感染是否会影响淋病奈瑟菌抗菌药物耐药性(AMR)监测的可靠性。在这项研究中,我们旨在通过在澳大利亚悉尼的高危人群中从淋病阳性标本中进行密集采样来解决这个问题。
共对 615 株淋病奈瑟菌分离株(来自 63 份临床样本,包括 31 份直肠拭子和 32 份咽拭子)进行了特征分析。所有分离株均进行了淋病奈瑟菌鉴定、抗菌药物敏感性测试和基于 SNP 的 MLST 基因分型。
仅 63 份样本中的 2 份(3.2%)提供了混合菌株感染的证据。这包括两个直肠拭子,其中包含不同 SNP 基于 MLST 基因型的分离株;然而,这些样本中不同基因型的 AMR 药敏谱是无法区分的。在另外 7 个样本中观察到了 AMR 药敏谱的样本内差异;然而,这些差异并不被认为是显著的;MIC 值通常在 2 倍差异范围内或接近测试临界点。
本研究的结果进一步证明了混合菌株淋病奈瑟菌感染确实会发生,尽管其发生率较低。我们的数据表明,在人群水平上,这种感染不太可能对淋病奈瑟菌 AMR 监测产生重大影响。